Cargando…

Comparative Efficacy of Xianling Gubao Capsules in Improving Bone Mineral Density in Postmenopausal Osteoporosis: A Network Meta-Analysis

OBJECTIVE: The clinical efficacy of Xianling Gubao capsule (XLGB) and its combination therapy in the treatment of postmenopausal osteoporosis (PMOP) was systematically evaluated by frequency-based network meta-analysis. METHODS: We searched the China National Knowledge Infrastructure (CNKI), Wanfang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ming-hui, Zhao, Jin-long, Xu, Nan-jun, Xiao, Xiao, Feng, Wen-xuan, Li, Zi-ping, Zeng, Ling-feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895757/ https://www.ncbi.nlm.nih.gov/pubmed/35250888 http://dx.doi.org/10.3389/fendo.2022.839885

Ejemplares similares

Chinese Proprietary Medicine Xianling Gubao Capsule for Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Cheng, Bai-Ru, et al.
Publicado: (2022)

Xianling Gubao Capsule Prevents Cadmium-Induced Kidney Injury
por: Huang, Jian, et al.
Publicado: (2021)

Efficacy and safety of Xianling Gubao capsule in treating postmenopausal osteoporosis: A protocol for systematic review and meta-analysis
por: Lou, Fanglian, et al.
Publicado: (2021)

Screening for Susceptibility-Related Factors and Biomarkers of Xianling Gubao Capsule-Induced Liver Injury
por: Li, Chun-yu, et al.
Publicado: (2020)

Efficacy of Xianling Gubao capsule in treating sarco-osteopenia: Protocol for a systematic review and meta-analysis
por: Chen, Qunqun, et al.
Publicado: (2019)

Chinese herbal medicine Xianling Gubao capsule for knee osteoarthritis: A protocol for systematic review and meta-analysis
por: Liu, Wang, et al.
Publicado: (2022)

The efficacy and safety of Xianling Gubao capsules in the treatment of knee osteoarthritis: A protocol for a randomized, double-blind, controlled trial
por: Wu, Jinfeng, et al.
Publicado: (2021)

Xianling Gubao attenuates high glucose-induced bone metabolism disorder in MG63 osteoblast-like cells
por: Chen, Xinlong, et al.
Publicado: (2022)

The Efficacy and Safety of Chinese Herbal Medicine Xianling Gubao Capsule Combined With Alendronate in the Treatment of Primary Osteoporosis: A Systematic Review and Meta-Analysis of 20 Randomized Controlled Trials
por: Chen, Jiaru, et al.
Publicado: (2021)

Effect of insulin resistance on gonadotropin and bone mineral density in nondiabetic postmenopausal women
por: Ye, Shujin, et al.
Publicado: (2023)

Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis
por: Wang, Qi-Fei, et al.
Publicado: (2020)

Serum Resistin Levels and Related Genetic Variants Are Associated With Bone Mineral Density in Postmenopausal Women
por: Tariq, Sundus, et al.
Publicado: (2022)

Associations of insulin resistance and insulin secretion with bone mineral density and osteoporosis in a general population
por: Fu, Yi-Hsiu, et al.
Publicado: (2022)

Association of selenium intake with bone mineral density and osteoporosis: the national health and nutrition examination survey
por: Peng, Shiyu, et al.
Publicado: (2023)

Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
por: Hu, Mingwei, et al.
Publicado: (2023)

Perirenalfat thickness is associated with bone turnover markers and bone mineral density in postmenopausal women with type 2 diabetes mellitus
por: Wang, Wei, et al.
Publicado: (2022)

Regulatory SNP of RREB1 is Associated With Bone Mineral Density in Chinese Postmenopausal Osteoporosis Patients
por: Feng, Shuo, et al.
Publicado: (2021)

Associations of Serum Cathepsin K and Polymorphisms in CTSK Gene With Bone Mineral Density and Bone Metabolism Markers in Postmenopausal Chinese Women
por: Gao, Li-hong, et al.
Publicado: (2020)

Follicle-stimulating hormone and blood lead levels with bone mineral density and the risk of fractures in pre- and postmenopausal women
por: Tong, Huixin, et al.
Publicado: (2022)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females
por: Tariq, Sundus, et al.
Publicado: (2022)

Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis
por: He, Jianquan, et al.
Publicado: (2020)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

Nerve conduction velocity is independently associated with bone mineral density in type 2 diabetes mellitus
por: Chen, Xiao-jing, et al.
Publicado: (2023)

Effect of Thyroxine and Thyrotropin on Bone Mineral Density in Postmenopausal Women: A Systematic Review
por: Poudel, Prakar, et al.
Publicado: (2022)

Associations of Fat Mass and Fat Distribution With Bone Mineral Density in Non-Obese Postmenopausal Chinese Women Over 60 Years Old
por: Fan, Jingzheng, et al.
Publicado: (2022)

Disturbed bone marrow adiposity in patients with Cushing’s syndrome and glucocorticoid- and postmenopausal- induced osteoporosis
por: Sørensen, Nina N., et al.
Publicado: (2023)

Proteomic profiling analysis of postmenopausal osteoporosis and osteopenia identifies potential proteins associated with low bone mineral density
por: Huang, Dageng, et al.
Publicado: (2020)

Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study
por: Xu, Yang, et al.
Publicado: (2022)

Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis
por: Shi, Zhen-Yu, et al.
Publicado: (2017)

Osteoporosis Risk Prediction for Bone Mineral Density Assessment of Postmenopausal Women Using Machine Learning
por: Yoo, Tae Keun, et al.
Publicado: (2013)

Vitamin D receptor gene polymorphisms, bone mineral density and fractures in postmenopausal women with osteoporosis
por: Horst-Sikorska, Wanda, et al.
Publicado: (2012)

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
por: Watts, N.B., et al.
Publicado: (2019)

Does Bone Mineral Apparent Density Facilitate Accurate Identification of Osteoporosis in the Short Postmenopausal Women?
por: Subramaniam, Karthik, et al.
Publicado: (2020)

Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis
por: Migliorini, Filippo, et al.
Publicado: (2021)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
por: Catalano, Antonino, et al.
Publicado: (2021)

Effect of Lifestyle Modification Intervention Programme on Bone Mineral Density among Postmenopausal Women with Osteoporosis
por: Anupama, D.S, et al.
Publicado: (2023)

Evaluation of bone mineral density and bone turnover in children on anticoagulation
por: Thom, Katharina, et al.
Publicado: (2023)

Effectiveness of Yushen Hezhi therapy for postmenopausal osteoporosis: An overview of systematic reviews of randomized controlled trials
por: Zhao, Jinlong, et al.
Publicado: (2022)

Bone Microarchitecture in Obese Postmenopausal Chinese Women: The Chinese Vertebral Osteoporosis Study (ChiVOS)
por: Qi, Wenting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_27ami5k9b0q7imuj5tqbj2rfsl